CHAPTERS
Reconnecting at the comedy club and why MAPS matters
Joe and Rick open with catching up after seeing each other at Joe’s club and talking about Dave Chappelle’s interest in psychedelic therapy. Joe frames MAPS’ work as culturally important, setting up a conversation that blends personal history, policy, and clinical science.
Draft resistance, civil disobedience, and an unlikely alliance with veterans
Rick recounts refusing to register for the Vietnam draft and how civil disobedience shaped his worldview. The conversation turns to how his later work helping veterans with PTSD feels like a meaningful reconciliation of values.
Vietnam, Gulf of Tonkin, Ellsberg, and finding common ground across divides
Joe and Rick discuss the Vietnam War’s legacy and how misinformation (like Gulf of Tonkin) fueled escalation. Rick shares insights from Daniel Ellsberg and pivots to a broader theme: building bridges with people you disagree with politically.
Bridge-building in practice: conservatives, celebrities, and controversial donations
Rick gives concrete examples of MAPS’ bipartisan coalition-building, from SEAL communities and Rick Perry to an unexpected connection with Ted Nugent. He also explains the backlash he received for accepting a restricted donation from Rebekah Mercer—and Stephen Breyer’s advice about democracy and common ground.
Joe’s psychedelic worldview: DMT and 5-MeO as ‘onion-peeling’ experiences
Rick invites Joe to share his own psychedelic experiences, and Joe describes DMT and 5-MeO-DMT as profoundly perspective-shifting. They explore how these states dissolve rigid ideologies, strip away “armor,” and confront the mystery of existence.
Integration and neuroplasticity: why duration and aftercare matter
The discussion moves from awe to mechanism: default mode network, integration, and neuroplasticity. Rick explains research suggesting longer psychedelic states can extend a post-session window of plasticity, emphasizing why structured therapy and follow-up are central.
Ibogaine: addiction recovery, policy failure, and Michael Marcus’ role
Joe asks about ibogaine in the context of the opioid crisis, and Rick argues it’s a prime example of disastrous drug scheduling. He shares the story of Aubrey Marcus’ father, Michael Marcus, whose ibogaine experience led to funding early research and expanding international projects.
Rick’s pivotal ibogaine + LSD experience: perfectionism, purging, and self-acceptance
Rick describes an intense initiation guided by underground therapy pioneer Leo Zeff, combining ibogaine with a high dose of LSD. The experience becomes a confrontation with self-perfectionism and self-hatred, leading to a lasting shift: retaining self-criticism while severing it from self-hate.
Drug war critique, language problems, and honesty about risks
After a brief break and a prostate-surgery/Burning Man bladder-control story, they return to drug war harms and the stigma embedded in words like “drugs” and “hallucinogens.” Both stress that reform requires honesty—acknowledging risks (e.g., cannabis-induced psychosis in vulnerable people) rather than propaganda.
MDMA myths and media propaganda: ‘holes in the brain’ and the meth mix-up retraction
Rick explains how sensational TV narratives amplified false claims that MDMA causes brain holes, including an MTV-to-Oprah pipeline. He then recounts the notorious Science paper claiming MDMA damages dopamine (Parkinson’s risk), later retracted when it turned out methamphetamine was administered by mistake.
Leary-era research lessons: Good Friday follow-up and the Concord Prison fraud
Rick details his long-term follow-up of the 1962 Good Friday Experiment, showing lasting positive ‘fruits’ and also revealing omitted adverse events (Thorazine sedation). He then describes uncovering methodological fraud in Leary’s Concord Prison Experiment recidivism claims, concluding that psychedelics require aftercare and social support to produce durable behavioral change.
Scaling psychedelic therapy: conferences, police training, VAs, and ‘net zero trauma by 2070’
Rick outlines MAPS’ public-education strategy, including the Psychedelic Science conference and initiatives to train police in de-escalation during difficult trips. He expands to a long-horizon vision—reducing societal trauma across generations—while noting state-level momentum (Texas funding VA studies) and international interest (Iceland justice system pilots).
MAPS at the crossroads: FDA timeline, funding needs, and the risks of going public
Rick explains MAPS’ organizational structure (nonprofit owning a public benefit corporation), the enormous costs to reach approval and sustainability, and the tension between philanthropy and investor capital. Joe worries about mixing sacred substances with profit incentives; Rick argues public-benefit governance can mitigate but not eliminate that risk.
Data exclusivity, FDA process confidence, and what comes next for psilocybin and beyond
Rick describes how ‘data exclusivity’ (not patents) can create a temporary monopoly after approval, enabling reinvestment into further research. He also explains why he’s confident in FDA approval (Special Protocol Assessment, robust safety/efficacy, validated data) and previews the next wave—psilocybin approvals, plus future pathways for ibogaine and 5-MeO.
Parenting and rites of passage: Rick’s bar mitzvah lesson and his ‘best anti-drug strategy’
The conversation closes (in this excerpt) with Rick reflecting on spiritual disappointment at his bar mitzvah and how that shaped his thinking about rites of passage. He describes offering his kids supervised marijuana or MDMA at 13—which initially repelled them—and asks Joe how he plans to educate his own children about substances.
